Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis is a research paper published in CHEST Journal (2020). On theSindex it has a DataRank of 0.683. It has been cited 94 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.683
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: K23HL146942
National Heart, Lung, and Blood Institute
Grant: K23HL138190
NHLBI NIH HHS
Grant: R01 HL130796
NIH HHS
Grant: P51 OD011107
NIAID NIH HHS
Grant: R42 AI132012
NHLBI NIH HHS
Grant: T32 HL007605
NIEHS NIH HHS
Grant: P30 ES023513
National Institutes of Health
Grant: 5K23HL146942-05
Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
National Institutes of Health
Grant: 1K23HL138190-01
Elucidating the genomic determinants of outcomes in idiopathic pulmonary fibrosis
FWCI
6.03
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals